| For: | Mansour-Ghanaei F, Dehbashi N, Yazdanparast K, Shafaghi A. Efficacy of saccharomyces boulardii with antibiotics in acute amoebiasis. World J Gastroenterol 2003; 9(8): 1832-1833 [PMID: 12918131 DOI: 10.3748/wjg.v9.i8.1832] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v9/i8/1832.htm |
| Number | Citing Articles |
| 1 |
Scientific Opinion on the substantiation of health claims related to Saccharomyces cerevisiae var. boulardii CNCM I‐1079 and defence against pathogenic gastro‐intestinal microorganisms (ID 913, further assessment) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal 2012; 10(6) doi: 10.2903/j.efsa.2012.2717
|
| 2 |
Abhijit Banik, Suman Kumar Halder, Chandradipa Ghosh, Keshab Chandra Mondal. Recent Advancement in White Biotechnology Through Fungi. Fungal Biology 2019; doi: 10.1007/978-3-030-14846-1_3
|
| 3 |
Abbinaya Elangovan, Jessica R. Allegretti, Monika Fischer. Microbiota modulation-based therapy for luminal GI disorders: current applications of probiotics and fecal microbiota transplantation. Expert Opinion on Biological Therapy 2019; 19(12) doi: 10.1080/14712598.2019.1673725
|
| 4 |
Silvia Salvatore, Yvan Vandenplas. Bioactive Foods in Promoting Health. 2010; doi: 10.1016/B978-0-12-374938-3.00013-X
|
| 5 |
Ronald L. Koretz. Probiotics in Gastroenterology: How Pro Is the Evidence in Adults?. American Journal of Gastroenterology 2018; 113(8) doi: 10.1038/s41395-018-0138-0
|
| 6 |
|
| 7 |
Ener Cagri Dinleyici, Makbule Eren, Nihal Dogan, Serap Reyhanioglu, Zeynel Abidin Yargic, Yvan Vandenplas. Clinical efficacy of Saccharomyces boulardii or metronidazole in symptomatic children with Blastocystis hominis infection. Parasitology Research 2011; 108(3) doi: 10.1007/s00436-010-2095-4
|
| 8 |
GV Zuccotti, F Meneghin, C Raimondi, D Dilillo, C Agostoni, E Riva, M Giovannini. Probiotics in Clinical Practice: An Overview. Journal of International Medical Research 2008; 36(1_suppl) doi: 10.1177/14732300080360S101
|
| 9 |
Marie-Agnès Travers, Isabelle Florent, Linda Kohl, Philippe Grellier. Probiotics for the Control of Parasites: An Overview. Journal of Parasitology Research 2011; 2011 doi: 10.1155/2011/610769
|
| 10 |
V. Choudhary, A. Vohra, A. Madan, Tulasi Satyanarayana. Yeast Diversity in Human Welfare. 2017; doi: 10.1007/978-981-10-2621-8_5
|
| 11 |
Y Vandenplas, Elisabeth De Greef, Bruno Hauser, Thierry Devreker, G Veereman-Wauters. Probiotics and prebiotics in pediatric diarrheal disorders. Expert Opinion on Pharmacotherapy 2013; 14(4) doi: 10.1517/14656566.2013.771632
|
| 12 |
L.V. McFarland. The Microbiota in Gastrointestinal Pathophysiology. 2017; doi: 10.1016/B978-0-12-804024-9.00018-5
|
| 13 |
Ener Cagri Dinleyici, Makbule Eren, Metehan Ozen, Zeynel Abidin Yargic, Yvan Vandenplas. Effectiveness and safety ofSaccharomyces boulardiifor acute infectious diarrhea. Expert Opinion on Biological Therapy 2012; 12(4) doi: 10.1517/14712598.2012.664129
|
| 14 |
Olivia Mondal, Devanshi Khanna, Shalja Panwar, Shilpa Negi, Sneha Basu. Systematic Review on Therapeutic Applications of Yeast 'Saccharomyces'. International Journal of Scientific Research in Science and Technology 2021; doi: 10.32628/IJSRST218226
|
| 15 |
Barry Jenkins, Steven Holsten, Stig Bengmark, Robert Martindale. Probiotics: A Practical Review of Their Role in Specific Clinical Scenarios. Nutrition in Clinical Practice 2005; 20(2) doi: 10.1177/0115426505020002262
|
| 16 |
Tatiana Colombo Pimentel, Suellen Jensen Klososki, Michele Rosset, Carlos Eduardo Barão, Vanessa Aparecida Marcolino. Sports and Energy Drinks. 2019; doi: 10.1016/B978-0-12-815851-7.00014-0
|
| 17 |
V. N. Drozdov, K. I. Arefev, S. Yu. Serebrova, E. V. Shikh. Clinical efficacy of drugs based on probiotic strains of Saccharomyces boulardii. Meditsinskiy sovet = Medical Council 2020; (5) doi: 10.21518/2079-701X-2020-5-104-112
|
| 18 |
Bulent A. Besirbellioglu, Asim Ulcay, Mehmet Can, Hakan Erdem, Mehmet Tanyuksel, Ismail Yasar Avci, Engin Araz, Alaaddin Pahsa. Saccharomyces boulardiiand infection due toGiardia lamblia. Scandinavian Journal of Infectious Diseases 2006; 38(6-7) doi: 10.1080/00365540600561769
|
| 19 |
Shigeru Kamiya. Probiotics and Prebiotics in Food, Nutrition and Health. 2013; doi: 10.1201/b15561-18
|
| 20 |
Bratati Mukhopadhyay, Nirmal Kumar Ganguly. The Unexplored Role of Probiotics on the Parasitic Pathogens. Food and Nutrition Sciences 2014; 5(22) doi: 10.4236/fns.2014.522230
|
| 21 |
Rameesha Abid, Hassan Waseem, Jafar Ali, Shakira Ghazanfar, Ghulam Muhammad Ali, Abdelbaset Mohamed Elasbali, Salem Hussain Alharethi. Probiotic Yeast Saccharomyces: Back to Nature to Improve Human Health. Journal of Fungi 2022; 8(5) doi: 10.3390/jof8050444
|
| 22 |
Christina M. Surawicz. Prebiotics and Probiotics Science and Technology. 2009; doi: 10.1007/978-0-387-79058-9_21
|
| 23 |
Maria Liza M Gonzales, Leonila F Dans, Juliet Sio-Aguilar. Antiamoebic drugs for treating amoebic colitis. Cochrane Database of Systematic Reviews 2019; doi: 10.1002/14651858.CD006085.pub3
|
| 24 |
Xin Yang, Guowei Shu, Zhangteng Lei, Guanli Du, Zemin Liu, Jili Cao. Effect of Carbon Sources, Nitrogen Sources and Prebiotics on Growth of Saccharomyces Boulardii
. Acta Universitatis Cibiniensis. Series E: Food Technology 2019; 23(2) doi: 10.2478/aucft-2019-0013
|
| 25 |
Nabila Gulzar, Iqra Muqaddas Saleem, Saima Rafiq, Muhammad Nadeem. Oral Health by Using Probiotic Products. 2019; doi: 10.5772/intechopen.86762
|
| 26 |
Shruti Nagaraja, Serge Ankri. Target identification and intervention strategies against amebiasis. Drug Resistance Updates 2019; 44 doi: 10.1016/j.drup.2019.04.003
|
| 27 |
Fereshteh Ansari, Shohre Alian Samakkhah, Ali Bahadori, Seyedeh Maedeh Jafari, Mojtaba Ziaee, Mohammad Taghi Khodayari, Hadi Pourjafar. Health-promoting properties of Saccharomyces cerevisiae var. boulardii as a probiotic; characteristics, isolation, and applications in dairy products. Critical Reviews in Food Science and Nutrition 2023; 63(4) doi: 10.1080/10408398.2021.1949577
|
| 28 |
Afreen Inam, Robyn L. Van Zyl, Natasha J. van Vuuren, Chien-Teng Chen, Fernando Avecilla, Subhash M. Agarwal, Amir Azam. Chloroquinoline–acetamide hybrids: a promising series of potential antiprotozoal agents. RSC Advances 2015; 5(60) doi: 10.1039/C5RA05472A
|
| 29 |
Hayat S. Al-Rashidi, Eman S. El-Wakil. Parasites and Microbiota: Dual Interactions and Therapeutic Perspectives. Microorganisms 2024; 12(10) doi: 10.3390/microorganisms12102076
|
| 30 |
Ener Cagri Dinleyici, Ates Kara, Metehan Ozen, Yvan Vandenplas. Saccharomyces boulardiiCNCM I-745 in different clinical conditions. Expert Opinion on Biological Therapy 2014; 14(11) doi: 10.1517/14712598.2014.937419
|
| 31 |
David C Montrose, Martin H Floch. Probiotics Used in Human Studies. Journal of Clinical Gastroenterology 2005; 39(6) doi: 10.1097/01.mcg.0000165649.32371.71
|
| 32 |
Y Vandenplas, B Hauser, E De Greef, T Devreker, G Veereman-Wauters. Probiotics and Prebiotics in Food, Nutrition and Health. 2013; doi: 10.1201/b15561-15
|
| 33 |
Nasrin Dashti, Mitra Zarebavani. Probiotics in the management of Giardia duodenalis: an update on potential mechanisms and outcomes. Naunyn-Schmiedeberg's Archives of Pharmacology 2021; 394(9) doi: 10.1007/s00210-021-02124-z
|
| 34 |
Maria Liza M Gonzales, Leonila F Dans, Elizabeth G Martinez. Antiamoebic drugs for treating amoebic colitis. Cochrane Database of Systematic Reviews 2009; doi: 10.1002/14651858.CD006085.pub2
|
| 35 |
Ahmed S. Kamel, Ahmed F. Mohamed, Mostafa A. Rabie, Marwa E. Elsherbiny, Kawkab A. Ahmed, Mahmoud M. Khattab, Noha F. Abdelkader. Experimental Evidence for Diiodohydroxyquinoline-Induced Neurotoxicity: Characterization of Age and Gender as Predisposing Factors. Pharmaceuticals 2022; 15(2) doi: 10.3390/ph15020251
|
| 36 |
Luis Vitetta, Emma Saltzman, Tessa Nikov, Isabelle Ibrahim, Sean Hall. Modulating the Gut Micro-Environment in the Treatment of Intestinal Parasites. Journal of Clinical Medicine 2016; 5(11) doi: 10.3390/jcm5110102
|
| 37 |
Grettel García-Collinot, Eduardo Osiris Madrigal-Santillán, Michel A. Martínez-Bencomo, Rosa A. Carranza-Muleiro, Luis J Jara, Olga Vera-Lastra, Daniel H. Montes-Cortes, Gabriela Medina, María Pilar Cruz-Domínguez. Effectiveness of Saccharomyces boulardii and Metronidazole for Small Intestinal Bacterial Overgrowth in Systemic Sclerosis. Digestive Diseases and Sciences 2020; 65(4) doi: 10.1007/s10620-019-05830-0
|
| 38 |
Y. Vandenplas, S. Salvatore, M. Viera, T. Devreker, B. Hauser. Probiotics in infectious diarrhoea in children: are they indicated?. European Journal of Pediatrics 2007; 166(12) doi: 10.1007/s00431-007-0497-9
|
| 39 |
Jean-Paul Buts. Twenty-Five Years of Research on Saccharomyces boulardii Trophic Effects: Updates and Perspectives. Digestive Diseases and Sciences 2009; 54(1) doi: 10.1007/s10620-008-0322-y
|
| 40 |
Vivian Moura-Oliveira, Fabrício M. S. Oliveira, Olga L. M. Moreno, Julia R. Ferreira, Raphael E. Szawka, Ana C. Campideli-Santana, Jullia Teles, Luciano S. A. Capettini, Flaviano S. Martins, Maria A. Gomes. Amebicidal Activity of Escherichia coli Nissle 1917 Against Entamoeba histolytica. Microorganisms 2025; 13(4) doi: 10.3390/microorganisms13040828
|
| 41 |
Annalisa Passariello, Pascal Agricole, Peter Malfertheiner. A critical appraisal of probiotics (as drugs or food supplements) in gastrointestinal diseases. Current Medical Research and Opinion 2014; 30(6) doi: 10.1185/03007995.2014.898138
|
| 42 |
Lotem Sarid, Eva Zanditenas, Jun Ye, Meirav Trebicz-Geffen, Serge Ankri. Insights into the Mechanisms of Lactobacillus acidophilus Activity against Entamoeba histolytica by Using Thiol Redox Proteomics. Antioxidants 2022; 11(5) doi: 10.3390/antiox11050814
|
| 43 |
Jing-Jing Shen, Baochuan Guo. Pouchitis and Ileal Pouch Disorders. 2019; doi: 10.1016/B978-0-12-809402-0.00043-5
|
| 44 |
Lorena Vívien Neves de Oliveira, Rafael Wesley Bastos, Noelly de Queiroz Ribeiro, Marliete Carvalho Costa, Leonardo Borges Acurcio, Karen Maia Rocha, Julliana Ribeiro Alves Santos, Rosana de Carvalho Cruz, Betânia Maria Soares, Daniel Assis Santos. In vivo probiotic and antimicrobial photodynamic therapy as alternative therapies against cryptococcosis are ineffective. Veterinary Microbiology 2017; 211 doi: 10.1016/j.vetmic.2017.08.015
|
| 45 |
Martin H. Floch, David C. Montrose. Use of Probiotics in Humans: An Analysis of the Literature. Gastroenterology Clinics of North America 2005; 34(3) doi: 10.1016/j.gtc.2005.05.004
|
| 46 |
Monika E. Jach, Anna Serefko. Diet, Microbiome and Health. 2018; doi: 10.1016/B978-0-12-811440-7.00009-0
|
| 47 |
|
| 48 |
H. Kumura, Y. Tanoue, M. Tsukahara, T. Tanaka, K. Shimazaki. Screening of Dairy Yeast Strains for Probiotic Applications. Journal of Dairy Science 2004; 87(12) doi: 10.3168/jds.S0022-0302(04)73546-8
|
| 49 |
Grażyna Karpińska, Aleksander P. Mazurek, Jan Cz. Dobrowolski. On tautomerism and substituent effect in 8-hydroxyquinoline-derived medicine molecules. Journal of Molecular Structure: THEOCHEM 2010; 961(1-3) doi: 10.1016/j.theochem.2010.09.006
|
| 50 |
Eman M. H. Méabed, Dalia N. Abdelhafez, Yasser F. Abdelaliem. Saccharomyces boulardii inhibits the expression of pro-inflammatory cytokines and inducible nitric oxide synthase genes in the colonic mucosa of rats experimentally-infected with Blastocystis subtype-3 cysts. Parasitology 2019; 146(12) doi: 10.1017/S0031182019000696
|
| 51 |
Lotem Sarid, Serge Ankri. Are Metabolites From the Gut Microbiota Capable of Regulating Epigenetic Mechanisms in the Human Parasite Entamoeba histolytica?. Frontiers in Cell and Developmental Biology 2022; 10 doi: 10.3389/fcell.2022.841586
|
| 52 |
Sudeshna Mandal, Chandrani Mondal, Larisha M. Lyndem. Probiotics: an alternative anti-parasite therapy. Journal of Parasitic Diseases 2024; 48(3) doi: 10.1007/s12639-024-01680-4
|
| 53 |
M. Ratna Sudha. Safety assessment studies of probiotic Saccharomyces boulardii strain Unique 28 in Sprague-Dawley rats. Beneficial Microbes 2011; 2(3) doi: 10.3920/BM2011.0013
|
| 54 |
Catherine Ulbricht, Tantri Budiman, Wendy Chao, Shaina Tanguay-Colucci, Julie Conquer, Dawn Costa, Richard Isaac, Joseph Parriott, Amarita Randhawa, Erica Rusie, Jill M. Grimes Serrano, Minney Varghese, Jen Woods, Sara Zhou. Probiotics (Bifidobacterium, Lactobacillus, and Saccharomyces boulardii): An Evidence-Based Systematic Review by the Natural Standard Research Collaboration. Alternative and Complementary Therapies 2011; 17(6) doi: 10.1089/act.2011.17601
|
| 55 |
Nitya Sarjapuram, Niharika Mekala, Meetali Singh, Utpal Tatu. The Potential of Lactobacillus casei and Entercoccus faecium Combination as a Preventive Probiotic Against Entamoeba. Probiotics and Antimicrobial Proteins 2017; 9(2) doi: 10.1007/s12602-016-9232-z
|
| 56 |
Serge Ankri. Entamoeba histolytica—Gut Microbiota Interaction: More Than Meets the Eye. Microorganisms 2021; 9(3) doi: 10.3390/microorganisms9030581
|
| 57 |
Fabrício Marcus Silva Oliveira, Greice Kelly Silva Prado, Ruth Elizabeth Cruz, Maria Aparecida Gomes, Marcelo Vidigal Caliari. Amoebiasis and probiotics: perspectives on complementary treatment. Reviews and Research in Medical Microbiology 2023; 34(4) doi: 10.1097/MRM.0000000000000367
|
| 58 |
Theodoros Kelesidis, Charalabos Pothoulakis.
Efficacy and safety of the probiotic
Saccharomyces boulardii
for the prevention and therapy of gastrointestinal disorders
. Therapeutic Advances in Gastroenterology 2012; 5(2) doi: 10.1177/1756283X11428502
|
| 59 |
Richard N. Fedorak, Karen L. Madsen. Probiotics and prebiotics in gastrointestinal disorders. Current Opinion in Gastroenterology 2004; 20(2) doi: 10.1097/00001574-200403000-00017
|
| 60 |
Jensine A. Grondin, Asif Jamal, Sadrina Mowna, Tyler Seto, Waliul I. Khan. Interaction between Intestinal Parasites and the Gut Microbiota: Implications for the Intestinal Immune Response and Host Defence. Pathogens 2024; 13(8) doi: 10.3390/pathogens13080608
|
| 61 |
Sylvia Cruchet, Raquel Furnes, Aldo Maruy, Eduardo Hebel, Jorge Palacios, Fernando Medina, Nelson Ramirez, Marina Orsi, Lysette Rondon, Vera Sdepanian, Luis Xóchihua, Manuel Ybarra, Roberto Arturo Zablah. The Use of Probiotics in Pediatric Gastroenterology: A Review of the Literature and Recommendations by Latin-American Experts. Pediatric Drugs 2015; 17(3) doi: 10.1007/s40272-015-0124-6
|
| 62 |
Luciana Laranjo Amorim Ventura, Dirce Ribeiro de Oliveira, Maria Aparecida Gomes, Marcia Regina Fantoni Torres. Effect of probiotics on giardiasis. Where are we?. Brazilian Journal of Pharmaceutical Sciences 2018; 54(2) doi: 10.1590/s2175-97902018000217360
|
| 63 |
G.K.S. Prado, K.C. Torrinha, R.E. Cruz, A.B.B. Gonçalves, C.A.V. Silva, F.M.S. Oliveira, A.C. Nunes, M.A. Gomes, M.V. Caliari.
Weissella paramesenteroides
WpK4 ameliorate the experimental amoebic colitis by increasing the expression of MUC‐2 and the intestinal epithelial regeneration
. Journal of Applied Microbiology 2020; 129(6) doi: 10.1111/jam.14671
|